SIBO Breath Test in Northern Virginia and H. pylori Testing

← Patient Education

A SIBO breath test in Northern Virginia is one of two very different tests that both happen to be done by breathing into a collection bag. The other is the urea breath test for Helicobacter pylori, the bacterium behind most stomach ulcers. They share a delivery method and almost nothing else: different organisms, different parts of the digestive tract, different preparation, and very different levels of diagnostic certainty. This page explains what each test measures, who each one is for, how to prepare, and what a result does and does not prove.

What a breath test measures

Breath testing works on a simple premise. Some microbes in your digestive tract produce gases that your body cannot make on its own. Those gases cross into the bloodstream, travel to the lungs, and leave in your breath, where they can be measured. Give the microbes something to work on, collect breath at intervals, and the pattern of gas over time says something about what is living where.

The appeal is that nothing is invasive. There is no scope, no sedation, no recovery, and no one has to drive you home. You sit in a chair, breathe into a bag or a tube at set intervals, and go about your day. That convenience is real, and it is also why breath tests get ordered in situations where a more definitive test would answer the question better. Which test is appropriate depends entirely on what is being asked.

The urea breath test for H. pylori

Helicobacter pylori is a bacterium that lives in the lining of the stomach. The American College of Gastroenterology's 2024 guideline on treatment of H. pylori infection puts its prevalence in North America at 30 to 40 percent, and notes that it is typically acquired in childhood. It is often silent for decades. When it does cause trouble, it causes gastritis and peptic ulcers. The World Health Organization recognizes H. pylori as a group I, or definite, carcinogen, which is the reason the guideline states that all patients found to be infected should be treated.

The test itself takes advantage of an enzyme the bacterium produces. The National Institute of Diabetes and Digestive and Kidney Diseases describes it this way: you swallow a capsule, liquid, or pudding that contains urea labeled with a special carbon atom. If H. pylori is present, the bacteria break the urea down into carbon dioxide, which carries the labeled carbon atom out through your lungs. You then breathe into a container, and the exhaled breath is analyzed for those labeled carbon atoms. Labeled carbon in your breath means the organism is there and active.

That word, active, is the key distinction. A blood antibody test can show that your immune system met H. pylori at some point, which may have been thirty years and one course of antibiotics ago. The ACG guideline lists urea breath testing, fecal antigen testing, and endoscopic biopsy-based testing as the appropriate methods, and advises avoiding serologic testing. Blood testing is the one most likely to send a patient down the wrong path.

Who should be tested for H. pylori

The ACG guideline sets out when testing is indicated rather than leaving it open-ended. On the benign side, that includes dyspepsia in patients under 60 without alarm features such as GI bleeding, vomiting, unexplained weight loss, or iron deficiency; a current or prior history of peptic ulcer disease; chronic NSAID use or starting daily aspirin therapy; unexplained iron deficiency anemia; immune thrombocytopenic purpura; and adult household members of someone who tests positive. Testing is also indicated in premalignant and malignant conditions, including gastric MALT lymphoma, gastric epithelial polyps, and high-risk premalignant findings such as atrophy, intestinal metaplasia, dysplasia, and autoimmune gastritis, along with a family history of gastric cancer.

The presence of alarm features changes the plan. The guideline directs patients with dyspepsia plus alarm features, NSAID use, a family history of gastric cancer, or immigration from a high incidence region toward endoscopy with biopsies rather than a breath test alone. In those situations an upper endoscopy both tests for the organism and looks at the tissue, and a breath test would only answer half the question. If unexplained weight loss or trouble swallowing is part of the picture, that is a conversation to have before any test is ordered.

There is a second use for the urea breath test, and it is one patients are often not told about. The ACG guideline states that all patients treated for H. pylori should undergo a test of cure at least four weeks after finishing therapy, using a urea breath test, a fecal antigen test, or a biopsy-based test. Treatment failure is common enough that confirming eradication is now standard, not optional. After eradication is confirmed, the guideline puts the recurrence rate at about 1 percent yearly.

Timing matters for accuracy on both the initial test and the test of cure. To avoid a false negative, proton pump inhibitors should be held for at least two weeks beforehand, and bismuth and antibiotics for at least four weeks. H2 blockers and antacids do not affect accuracy. Never stop a prescribed medication on your own to prepare for a test; tell us what you take and we will tell you what to hold and for how long.

What a SIBO breath test in Northern Virginia looks for

Small intestinal bacterial overgrowth is a different problem entirely. The small intestine normally carries far fewer bacteria than the colon, kept in check by stomach acid, bile, pancreatic enzymes, the ileocecal valve, mucosal immunity, and the sweeping contractions that clear the small bowel between meals. When those defenses falter, colonic-type bacteria establish themselves where they do not belong and ferment food before it can be absorbed.

A SIBO breath test in Northern Virginia measures the byproducts of that fermentation. You drink a measured sugar solution, and breath samples are collected at intervals over two to three hours. Human cells do not produce hydrogen or methane; gut microbes do. A rise in those gases early in the test suggests fermentation is happening high in the small bowel rather than down in the colon where it belongs.

The ACG's 2020 clinical guideline on small intestinal bacterial overgrowth, published in the American Journal of Gastroenterology, specifies the standardized doses: 75 grams of glucose or 10 grams of lactulose, taken with or followed by about one cup of water. Following the North American Consensus, the guideline describes a rise in exhaled hydrogen of at least 20 parts per million above baseline within 90 minutes as diagnostic of SIBO. A second, later peak is not required, but the first peak has to fall inside that 90 minute window for the test to count as positive.

Methane is measured at the same time and means something different. A methane level of at least 10 parts per million at any point during the test indicates methanogen overgrowth. The ACG guideline is precise about why that is not the same finding: methanogens are not bacteria at all but archaea, and they can overgrow in the colon rather than only the small intestine, so the guideline proposes the separate term intestinal methanogen overgrowth, or IMO. The practical significance is that elevated methane tends to travel with constipation, while hydrogen-predominant overgrowth more often shows up with diarrhea.

Who a SIBO breath test in Northern Virginia is for

The ACG guideline names bloating as the most common symptom of SIBO. The broader symptom set includes nausea, flatulence, abdominal distension, cramping, abdominal pain, diarrhea, and constipation, which is a description that fits an enormous number of people who do not have bacterial overgrowth. That overlap is exactly why the guideline attaches testing to specific clinical situations instead of to symptoms alone.

It suggests breath testing with glucose or lactulose in three groups: patients with irritable bowel syndrome; symptomatic patients with suspected motility disorders; and symptomatic patients with abdominal pain, gas, bloating, or diarrhea who have had previous abdominal surgery involving the bowel. It separately suggests testing for methane in symptomatic patients with constipation. Each of those recommendations is graded conditional, with a very low level of supporting evidence, and the guideline says so plainly.

The conditions that predispose to overgrowth explain the pattern. Motility disorders such as scleroderma and diabetes disrupt the migrating motor complex that clears the small bowel between meals, as can opioids, antidiarrheals, and anticholinergic medications. Surgery matters when it changes the plumbing, particularly loss of the ileocecal valve, Roux-en-Y anatomy, or a blind loop. Small bowel diverticulosis, radiation strictures, and adhesions do the same. Advanced age and female sex are associated with higher likelihood. If you have gastroparesis or another known motility problem, overgrowth is a reasonable thing to look for.

There is also a group the guideline suggests against testing. It advises against breath testing for SIBO in asymptomatic patients taking proton pump inhibitors. Reduced stomach acid can shift bacterial counts without producing illness, and testing people who feel fine mainly generates results that invite treatment nobody needed.

How to prepare for a SIBO breath test in Northern Virginia

Preparation is not a formality. It is most of what separates a usable result from a meaningless one, because everything the test measures is fermentation, and anything still fermenting in your gut from yesterday will be measured right along with it.

The ACG guideline describes the preparation as avoiding fermentable foods such as complex carbohydrates before the test, then fasting for 8 to 12 hours. During the test itself, patients should avoid smoking and minimize physical exertion. Both alter the gases in exhaled breath and can push a result across a threshold in either direction. Plan on sitting quietly for the duration, and bring something to read.

Medications and recent antibiotics also affect results, and laxative or antibiotic exposure in the preceding weeks can suppress the very organisms being measured. Bring a complete list of your prescriptions, over-the-counter medications, and supplements, including probiotics, to the visit where testing is discussed. Our first visit guide covers what else to bring and what that appointment involves.

What the results mean, and what they do not

Here is the part that gets skipped in most patient-facing material about SIBO, and we would rather you hear it before the test than after. The ACG guideline reports that in a systematic review, the sensitivity of lactulose breath testing ranged from 31 to 68 percent and specificity from 44 to 100 percent, while glucose breath testing ranged from 20 to 93 percent sensitivity and 30 to 86 percent specificity when compared against cultures taken directly from the small bowel. Those are wide ranges, and they mean a breath test can miss overgrowth that is present and can flag overgrowth that is not.

What follows from that is a matter of interpretation rather than arithmetic. A positive test in someone with the right symptoms and a clear predisposing cause is informative. A positive test in someone with no symptoms is close to meaningless. A negative test in someone with significant symptoms does not close the case and does not mean nothing is wrong; it means the next step is to look elsewhere. Conditions such as celiac disease, carbohydrate intolerance, pancreatic insufficiency, and inflammatory bowel disease produce overlapping symptoms and are found with different tests. Our page on chronic bloating and gas walks through that broader differential.

The urea breath test sits in a different place. It is a well-validated test for a single organism with a defined treatment, and it answers a yes or no question with high accuracy when the preparation rules are followed. Reading a SIBO result requires the same care as reading any test with imperfect performance characteristics: in the context of your history, your medications, your anatomy, and your symptoms, and by a physician who is prepared to act on a negative as readily as on a positive.

What happens after a positive test

For H. pylori, the path is well defined. The ACG guideline provides specific regimens, generally combining acid suppression with two or more antibiotics for 14 days, and the choice depends on prior antibiotic exposure, local resistance patterns, allergies, and in some cases susceptibility testing. Rising clarithromycin and levofloxacin resistance has changed which regimens are recommended first, which is why current guidance matters and why the four-week test of cure afterward is not optional.

For SIBO, the ACG guideline suggests the use of antibiotics in symptomatic patients to eradicate overgrowth and resolve symptoms, again as a conditional recommendation based on a low level of evidence. A meta-analysis of 32 studies of rifaximin covering 1,331 patients found an overall intention-to-treat success rate of 70.8 percent with adverse reactions in 4.6 percent, across trials that varied widely in dose and duration. The guideline also notes a lack of consistent data supporting any specific probiotic for treating SIBO, and no current basis for fecal microbiota transplant.

Recurrence is the harder problem, and the guideline addresses it directly: prevention matters, and treating the underlying cause is the primary way to prevent recurrence. Antibiotics clear the overgrowth; they do not repair the motility problem, the surgical anatomy, or the medication effect that allowed it. When symptoms return after months, the productive question is what conditions in the small bowel keep favoring overgrowth, not which antibiotic to try next. The guideline also notes that retesting after treatment may correlate with symptom improvement and can be confirmed by normalization of hydrogen or methane levels.

Talk with GC of NoVA about breath testing

Both of these tests are worth doing when the clinical question calls for them, and both are worth skipping when it does not. That decision comes out of an office visit: your symptom pattern, your medication list, your surgical history, and what has already been ruled out. Our physicians will explain which test fits your situation, where it would be performed, how to prepare, and what a result would and would not settle before anything is scheduled.

Gastroenterology Center of Northern Virginia sees patients at our Arlington office at 1715 N George Mason Drive, adjacent to VHC Health, and our Annandale office at 3299 Woodburn Road in the Woodburn Medical complex near Inova Fairfax Hospital. Call Arlington at (703) 522-7476 or Annandale at (703) 560-6106, or visit gcofnova.com. Office hours are Monday through Thursday 8:30 a.m. to 5:00 p.m. and Friday 8:30 a.m. to 4:30 p.m. We are accepting new patients at both locations.

This article is for general education and is not medical advice. Whether breath testing is appropriate for you, and how to prepare for it, depends on your symptoms, your medications, and your medical history. Talk with a qualified gastroenterologist about your symptoms, diagnosis, and treatment options.